Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society

Strides Made in 2014 Toward a World Free of MS
Logo eNews
December 2014
Donate Now
More MS News Join the Community Find an Event Advocate for Change In Your Area
eNEWS: 2014 MS Research Breakthroughs You Should Know About

Strides Made in 2014 Toward a World Free of MS

Significant research progress was made in 2014, offering new leads that are driving efforts to stop MS in its tracks, restore function, and end MS forever. In 2015, the Society is committed to fueling research by increasing its annual investment to over $52 million - because understanding and ending MS can’t come fast enough.
See the Progress
Announcing Access to Care Principles

Announcing Access to Care Principles

The Society has adopted principles that will guide efforts to ensure everyone with MS has access to affordable, high quality healthcare.These principles are the foundation for the Society’s advocacy, communication, programmatic and research strategies.

Learn More
FDA Approves LemtradaTM for Relapsing MS

FDA Approves Lemtrada™ for Relapsing MS

Lemtrada™ is the latest disease-modifying therapy approved by the FDA for people with relapsing forms of MS. Delivered through intravenous infusions for 5 consecutive days initially, and for 3 consecutive days one year later, this treatment is now available by prescription.

Read More

Every Connection Counts

From fundraising events to influencing policy to giving financially, everyone can make a difference.
Join the Conversation
Join the Conversation

Find and share tips on avoiding holiday burn-out, stress and fatigue.

Discuss Here
Advocate for Change
Advocate for Change

We all have a story that can drive change.

Take Action
Year-End Giving Starts Now
Year-End Giving Starts Now

Don’t delay. Give your 2014 tax-deductible year-end gift today.

Give Now
Donate Now JOIN US FaceBookTwitterLinkedInYoutubePintrest
This communication is partially sponsored through the generous support of Biogen Idec; Genzyme, a Sanofi company; Mylan Inc.; Novartis Pharmaceuticals Corporation; and
Teva Neuroscience, Inc.
Genzyme Logo Biogen Idec Mylan - Seeing is Believing
Novartis   Teva 

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our website.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to   .
To ensure that you continue to receive our emails, please add us to your address book.